Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients - Test2 - elhamkhani - TriplyDB

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

http://www.wikidata.org/entity/Q35006871

about

The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas The significance of markers in the diagnosis of endometrial cancer Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis.Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients.Surgical management of early endometrial cancer: an update and proposal of a therapeutic algorithm Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.The human epididymis protein 4 acts as a prognostic factor and promotes progression of gastric cancer Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.Expression of HE4 in Endometrial Cancer and Its Clinical Significance HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.Assessment of levels of the tumor markers HE4 and CA125 considering staging, grading and histological types of endometrial cancer.Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.Endometrial and Ovarian Cancer with MR Imaging Importance of Serum HE4 and CA 125 Levels in the Extent of Disease at Evaluation.Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples.Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease.Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.A critical review on HE4 performance in endometrial cancer: where are we now?Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset.Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis.KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation.Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies.Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer.Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4.RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients.HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia.Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer.HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).Splice variant HE4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma.Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression.The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients.The role of novel biomarker HE4 in endometrial cancer: a case control prospective study.Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer.Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study.Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers.Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature.The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program.Serum endocan levels in endometrial and ovarian cancers.

P2860

Q26992102-E4E561CF-580E-4263-A8F9-F15E06847A42 Q28067066-D85B5608-21F4-4C50-B748-9463BA4CE793 Q33729850-4813414F-E623-41B6-B7B3-11DEBDA905D5 Q33879185-33EBA373-EDFF-445E-A6FF-B28B7E60273C Q34062135-BEE42130-D83C-430E-8059-38D9BB9ACB2B Q35128002-547363B4-C9F2-4E6A-AF13-E62E04CB41D2 Q35596885-5909F067-B3E6-4E3F-862F-A7C621FE4639 Q35612779-C9D39C7D-FF7A-41F6-A319-1499DA6B4C47 Q35688448-6A38EB9B-E571-4D84-9154-CD75CB45124E Q36053925-54A5BFCC-43E1-46F1-8FC3-531BD982B33E Q36204114-04660AAA-4ED2-40B2-95F2-C016BDED9858 Q36790307-75CFCD23-A3B8-4AF5-A5AE-002FAB44832A Q37375504-4161582F-B4DE-4CCB-A2A5-AF781DA11214 Q37473123-B8B647D0-FF22-4D67-8F10-B9BAC1453A96 Q37553857-6C3F8D1C-A234-4110-B21A-81DE3FFC95A7 Q37608781-3E2FB413-C92E-4508-8FF6-1934DC839427 Q37619708-E71A109B-0BB1-4E58-8592-74E35BA41F6F Q37708699-7E50D800-D716-4C20-BF99-277C4C0F095D Q37960202-D76EAF75-9D55-4E3D-97F2-0EE3AFAFEB58 Q38143730-7AD561BC-C568-4638-A17A-54779F889C5F Q38846968-5D066300-55C8-4757-8CCB-26CA8118623F Q38958066-4F1CCE1C-3D03-4500-BC1F-88447A1A12C4 Q38984603-1622536B-8820-44B0-AEBD-4F145F720F12 Q38991579-C604052F-02B0-4D8D-8ADD-2514347B0B56 Q39014460-E4364057-5E7B-413E-984B-1DF245E8FCF2 Q39021988-8278D6B9-5901-43DA-BABB-A205C95F5BFE Q40056725-9675DB20-EA6A-4D3F-B5C8-06264AC8B153 Q41095997-26EF3113-130C-4FF7-AF1B-615C635B939A Q42659935-5DE3369B-778B-42CA-BAE5-C92FE145C315 Q43603831-4259B8CD-46E3-4A5E-A9A8-9CC296AA5483 Q43728520-A3A9878D-7A32-4599-B49D-D4931EABBD5D Q44234643-21D510E9-9B7A-4938-9B94-1C1FF3A792C1 Q44259160-891A581C-2E5D-4352-9EB7-3513C45D80F4 Q46748240-4BA57079-D873-4701-977C-75ADADF5B5E6 Q47134921-50C382DB-0C3D-493C-A40D-5C3BF895AA11 Q47644020-11163B68-2443-4366-9C1B-34C7025BA27D Q47660114-5ED7CDED-37B3-4E3E-8F94-1502943D42E4 Q47797102-806E68A4-2153-410D-872B-C6B08DE856FE Q47972647-FB133FC3-643A-4ED3-83EE-3FACAD64D786 Q47982714-BBE35A20-FDB0-4151-A897-F0C4DD2E516A

P2860

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

http://www.wikidata.org/entity/Q35006871

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

@ast

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

@en

type

label

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

@ast

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

@en

prefLabel

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

@ast

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

@en

P1433

Q35006871-2BF459F5-11A5-45E4-8062-0F432A86FA8A

P1476

Q35006871-32568DC7-CB23-4275-9618-AA2602EBC5A7

P2093

Q35006871-2FFD21FE-F8F0-4DFF-A2F2-D81B4EABD09C

Q35006871-47C9E47F-2805-4032-B26B-A8165AED361A

Q35006871-4E3611DC-26A2-4A15-A585-6CA7B1F94A8B

Q35006871-625FAA54-072A-4DE2-96FA-4B5DA7EB0BD3

Q35006871-80497961-6B21-42DE-B08A-18E5AC0A59CF

Q35006871-9CDBCCF2-6A6C-486C-8A32-466943B29289

Q35006871-9E7EC8C4-02FB-480C-91D7-9540D5613575

Q35006871-ED5326B9-A5B7-4FD7-943B-B72EE5ECB68F

Q35006871-F7F70C76-C9B9-4563-A7D6-AD03C516E447

P2860

Q35006871-16C2F25B-8461-4EE1-901F-A9FFBB025278

Q35006871-25FEE51A-F2FD-450D-81D8-AA4DA0C53823

Q35006871-29B2F9F9-E60D-49CB-BCE6-E8DDA2705223

Q35006871-3A274FB8-E294-4BF0-A042-64B960AF8EC1

Q35006871-44E16C4D-AC47-43D1-ADB8-C26D19A39A62

Q35006871-47ACDC2E-9CFC-4CE9-B2C3-19C783853ED3

Q35006871-4BC65B6D-EB63-47C7-8D02-4E3B08E03AA7

Q35006871-5D383E84-926C-4539-AE57-0684CF34C4C2

Q35006871-686C140A-6264-4857-9472-1B406ED05131

Q35006871-6FBDB2FD-638C-40A0-BCEC-539965499851

P2888

Q35006871-1A0EDA07-B3ED-4B9D-872B-F4DD3710F069

P304

Q35006871-6BB743DE-7927-428C-B967-17A75C863300

P31

Q35006871-1A5B818C-B97E-480B-AB55-19951649D0E2

P356

Q35006871-0B026AFD-8EF2-4ECE-B8D7-CCCE0E1F230C

P407

Q35006871-53955684-112F-4C51-94F7-4F7F3BAF863A

P433

Q35006871-EE577EE5-385B-4D2E-B557-4F86ECFC92E2

P478

Q35006871-88DC8817-B7C4-4E41-84B2-6BC66BEE58FC

P50

Q35006871-0A044AAA-AF6A-48A4-B8D9-25CBA25074EF

Q35006871-136220C2-47DD-4039-BC8E-C0DEC7D175F2

Q35006871-35A8FE1E-6534-4527-B4CB-C21AC7FD9197

Q35006871-93BC61D7-8678-475E-B3DF-E705447094DF

Q35006871-AA78E035-3C44-47D3-85D7-D092FC2EE79B

Q35006871-EF3E7D1D-617C-4DD7-8A4A-142D07535BD9

P577

Q35006871-4264B3BA-5174-49D3-9B88-4C2D35B01221

P5875

Q35006871-6C03119A-B33B-46A9-80C1-CEF38D689561

P698

Q35006871-BD343C2B-09EA-4AAF-A398-5036285BDF88

P932

Q35006871-4BB7CAA6-61D7-42E1-A4FD-C229019BC061

P356

P1433

British Journal of Cancer

P1476

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

@en

P2093

E Bandiera

http://www.w3.org/2001/XMLSchema#string

E Bignotti

http://www.w3.org/2001/XMLSchema#string

M Falchetti

http://www.w3.org/2001/XMLSchema#string

M Ragnoli

http://www.w3.org/2001/XMLSchema#string

P Todeschini

http://www.w3.org/2001/XMLSchema#string

R A Tassi

http://www.w3.org/2001/XMLSchema#string

S Bergamelli

http://www.w3.org/2001/XMLSchema#string

S Lonardi

http://www.w3.org/2001/XMLSchema#string

S Pecorelli

http://www.w3.org/2001/XMLSchema#string

P2860

A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

Theories of endometrial carcinogenesis: a multidisciplinary approach.

The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms.

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.

Two pathogenetic types of endometrial carcinoma.

Preoperative serum CA-125 levels in treating endometrial cancer.

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.

P2888

P304

1418-1425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2011.109

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Antonella Ravaggi

Fabio Facchetti

P577

2011-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51020606

http://www.w3.org/2001/XMLSchema#string

P698

21468050

http://www.w3.org/2001/XMLSchema#string

P932

3101927

http://www.w3.org/2001/XMLSchema#string